Zafirlukast

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 525 publications

Intra-cluster receptor density (IRD): A molecular switch for TNFR1 clusters' signaling.

Intra-cluster receptor density (IRD): A molecular switch for TNFR1 clusters' signaling.

Journal: Science advances
Published: September 02, 2026

Assessment of the binding characteristics of three antagonists toward CysLTR1 by affinity chromatography.

Assessment of the binding characteristics of three antagonists toward CysLTR1 by affinity chromatography.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: July 01, 2026

Zafirlukast Exacerbates Behavioral Seizure Activity and Blood-Brain Barrier Disruption Despite Modestly Reducing Neuronal Injury Markers in a PTZ-Induced Early Epileptogenesis Mouse Model.

Zafirlukast Exacerbates Behavioral Seizure Activity and Blood-Brain Barrier Disruption Despite Modestly Reducing Neuronal Injury Markers in a PTZ-Induced Early Epileptogenesis Mouse Model.

Journal: Molecular neurobiology
Published: June 08, 2026

Activation of TMEM175 lysosomal ion channels by CysLT1 receptor antagonists.

Activation of TMEM175 lysosomal ion channels by CysLT1 receptor antagonists.

Journal: American journal of physiology. Cell physiology
Published: February 11, 2026

Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension.

Sine oculis homeobox 1 drives endothelial dysfunction in preclinical pulmonary arterial hypertension.

Journal: Science translational medicine
Published: February 04, 2026

An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.

An In Silico and In Vitro Approach Identified Potential Trypanothione Synthetase Inhibitors with Trypanocidal Activity.

Journal: Molecules (Basel, Switzerland)
Published: January 27, 2026

Structure-based design of the approved drug zafirlukast identifies HLC40 as a potent WDR5 WIN-site inhibitor with antitumor efficacy.

Structure-based design of the approved drug zafirlukast identifies HLC40 as a potent WDR5 WIN-site inhibitor with antitumor efficacy.

Journal: Bioorganic chemistry
Published: January 22, 2026

In Silico identification of inhalable small-molecule IL-33/ST2 antagonists for severe type-2-high asthma endotypes.

In Silico identification of inhalable small-molecule IL-33/ST2 antagonists for severe type-2-high asthma endotypes.

Journal: Scientific reports
Published: December 23, 2025

An ELISA for discovering protein-protein interaction inhibitors: blocking lysinoalanine crosslinking between subunits of the spirochete flagellar hook as a test case.

An ELISA for discovering protein-protein interaction inhibitors: blocking lysinoalanine crosslinking between subunits of the spirochete flagellar hook as a test case.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Virtual screening and molecular dynamics simulations for drug repurposing against autophagy to attenuate blast in cereal plants.

Virtual screening and molecular dynamics simulations for drug repurposing against autophagy to attenuate blast in cereal plants.

Journal: Scientific reports
Published: October 27, 2025

Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor.

Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor.

Journal: Computers in biology and medicine
Published: October 23, 2025

Leukotriene receptor antagonists and eosinophilic granulomatosis with polyangiitis: a disproportionality analysis from FAERS, JADER, CVAR databases integrated with network pharmacology.

Leukotriene receptor antagonists and eosinophilic granulomatosis with polyangiitis: a disproportionality analysis from FAERS, JADER, CVAR databases integrated with network pharmacology.

Journal: PloS one
Published: October 14, 2025
Showing 1-12 of 525

Last Updated: 09/26/2026